Keyword: Harvard University

Civetta Therapeutics is launching with $53 million from Deerfield to develop drugs targeting beta-propeller proteins with a first focus in cancer.

Harvard University, MIT and other Massachusetts life sciences players are setting up a new manufacturing center, slated to open in 2021.

Researchers at Rejuvenate Bio say they have compelling evidence that gene therapy could treat diabetes, obesity, and heart and kidney failure.

A mesh of integrated, electric sensors aims to track the earliest stages of tissue development and differentiation.

Broad Institute researchers have developed an RNA-editing strategy that they believe could someday treat brain diseases like Alzheimer’s.

The week’s biotech news included one stem-cell-derived treatment for diabetes and another for regrowing hair.

A Harvard-led team has built brain organoids that mimic the cell types and connections that every human brain has.

The week’s biotech discoveries included compounds in broccoli and ragweed with potential disease-fighting properties.

Semma and Harvard scientists are reporting they've figured out how to regenerate high quantities of insulin-producing beta cells.

Verve Therapeutics is launching with $58.5 million access to CRISPR and base-editing tech and cardiologist and geneticist Sekar Kathiresan as CEO.